Dentsply Sirona (XRAY)
(Delayed Data from NSDQ)
$26.11 USD
-0.59 (-2.21%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $26.11 0.00 (0.00%) 6:56 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$26.11 USD
-0.59 (-2.21%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $26.11 0.00 (0.00%) 6:56 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Zacks News
Why an Earnings Beat is Likely for Waters Corp. (WAT) in Q2
by Zacks Equity Research
Waters Corp.'s (WAT) dominant position in the biopharma end markets and thriving sales in emerging markets will likely help it gain traction in the second quarter.
DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay
by Zacks Equity Research
On Jul 12, we issued an updated research report on NY-based DENTSPLY SIRONA Inc. (XRAY) -- a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products.
DENTSPLY SIRONA Renews Canadian Distribution Agreement
by Zacks Equity Research
DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced the renewal of an existing distribution agreement with Henry Schein Canada, Inc.
DENTSPLY (XRAY) Renews Partnership with Pacific Dental
by Zacks Equity Research
DENTSPLY SIRONA Inc. (XRAY), a dental solutions company, recently announced that it has renewed its strategic partnership with Pacific Dental Services, LLC.
DENTSPLY (XRAY) Earnings and Revenues Miss Estimates in Q1
by Zacks Equity Research
DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings per share of 49 cents in the first quarter of 2017, missing the Zacks Consensus Estimate by 2 cents.
DENTSPLY (XRAY) Q1 Earnings Miss Estimates, Sales Up Y/Y
by Zacks Equity Research
DENTSPLY reported adjusted earnings of 49 cents per share, which missed the Zacks Consensus Estimate by 2 cents.
Medical Product Q1 Earnings Due on May 9: XRAY, HSIC & More
by Zacks Equity Research
Medical product, an important part of the medical device subcategory within the broader Medical sector, looks promising at the moment.
Bull of the Day: Align Technology (ALGN)
by Kevin Cook
Clearly, investors will continue to smile with this 25% grower in their portfolios
Can DENTSPLY (XRAY) Pull a Surprise this Earnings Season?
by Zacks Equity Research
DENTSPLY Sirona Inc. (XRAY), a dental solutions company, is expected to report first-quarter 2017 results on May 5.
DENTSPLY Sirona Grapples with Multiple Issues: Dump Now?
by Zacks Equity Research
On Mar 20, we issued an updated research report on NY-based DENTSPLY Sirona Inc. (XRAY) -- a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products.
DENTSPLY (XRAY) Up 3.9% Since Earnings Report: Can It Continue?
by Zacks Equity Research
DENTSPLY (XRAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for February 28th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
DENTSPLY (XRAY) Beats on Earnings in Q4, Misses Revenues
by Zacks Equity Research
DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings per share of 67 cents in the fourth quarter of 2016, surpassing the Zacks Consensus Estimate by 2 cents.
DENTSPLY (XRAY) Q4 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
DENTSPLY reported adjusted earnings of 67 cents per share, which beat the Zacks Consensus Estimate by 2 cents and was higher than earnings of 65 cents in the year-ago quarter.
DENTSPLY (XRAY) Q4 Earnings: Is Disappointment in Store?
by Zacks Equity Research
York, PA-based DENTSPLY Sirona Inc. (XRAY), a dental solutions company, is expected to report fourth-quarter 2016 results on Feb 10.
MedTech Tailwinds at a Glance: Which Stocks to Buy?
by Zacks Equity Research
Positive demographic trends and new product innovation have been the vital force behind the continued uptrend of the sector???s performance.
5 MedTech Stocks Poised to Trump Earnings in Q4
by Zacks Equity Research
MedTech's steady earnings trend reflects a strong product cycle and continuing innovation.